|
|
Volumn 2, Issue 8, 1996, Pages 324-
|
|
Nitric oxide: moving towards the clinic.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ENZYME INHIBITOR;
N(G) METHYLARGININE;
NITRIC OXIDE;
NITRIC OXIDE SYNTHASE;
ANIMAL;
ARTERIOSCLEROSIS;
CONFERENCE PAPER;
DRUG ANTAGONISM;
HUMAN;
INFLAMMATION;
METABOLISM;
PATHOPHYSIOLOGY;
PHASE 1 CLINICAL TRIAL;
PULMONARY HYPERTENSION;
SEPTIC SHOCK;
ANIMALS;
ARTERIOSCLEROSIS;
CLINICAL TRIALS, PHASE I;
ENZYME INHIBITORS;
HUMANS;
HYPERTENSION, PULMONARY;
INFLAMMATION;
NITRIC OXIDE;
NITRIC OXIDE SYNTHASE;
OMEGA-N-METHYLARGININE;
SHOCK, SEPTIC;
|
|
EID: 16144367753
PISSN: 13574310
EISSN: None
Source Type: Journal
DOI: 10.1016/1357-4310(96)81795-3 Document Type: Conference Paper |
|
Times cited : (5)
|
|
References (0)
|
